Last reviewed · How we verify
NCT05477303
Artificial Intelligence to Evaluate Postoperative Pain Based on Facial Expression
trial testing taking a picture of a painful facial expression in Artificial Intelligence in 120 participants. Currently enrolling.
20 April 2023
Quick facts
| Lead sponsor | Seoul National University Bundang Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 17 June 2022 |
| Primary completion | 20 April 2023 |
| Estimated completion | 9 May 2026 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- taking a picture of a painful facial expression
Conditions studied
- Artificial Intelligence — all drugs for Artificial Intelligence →
- Facial Expression — all drugs for Facial Expression →
- Analgesia — all drugs for Analgesia →
- Pain, Postoperative — all drugs for Pain, Postoperative →
Sponsor
Seoul National University Bundang Hospital
Who can join
Adults 19 to 75, any sex, with Artificial Intelligence or Facial Expression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients' subjective complaints about pain intensity are difficult to objectively evaluate, and may lead to inadequate pain management, especially in patients with communication difficulties.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05477303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Artificial Intelligence
Currently open trials in the same condition.
- NCT07257796 — Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07261618 — AI-Assisted 2D Fetal Brain Ultrasound for Intracranial Anomaly Detection · active not recruiting
- NCT07098884 — Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos · recruiting
- NCT06978348 — Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology. · recruiting
Other Seoul National University Bundang Hospital trials
Trials by the same sponsor.
- NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
- NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
- NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05477303 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
- Last refreshed: 28 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05477303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing